TSX:TSNDPharmaceuticals
TerrAscend FY 2025 Losses Persist And Test Bullish Margin Improvement Narratives
TerrAscend FY 2025 Earnings Snapshot
TerrAscend (TSX:TSND) has reported its FY 2025 numbers, with third quarter revenue at US$65.1 million and basic EPS at a loss of US$0.04, while trailing twelve month revenue was US$299.5 million and EPS was a loss of US$0.24.
Over recent quarters, the company’s quarterly revenue moved from US$65.2 million in Q3 2024 to US$64.3 million in Q1 2025, US$65.0 million in Q2 2025 and US$65.1 million in Q3 2025. Over the same period, basic EPS losses were US$0.06,...